13F Pro

SEC Form 4 reporting owner

Foff Erin Pennock

Foff Erin Pennock has filed 27 Form 4 transactions reported between January 27, 2026 and August 17, 2026, as Chief Medical Officer of MapLight Therapeutics, Inc..

Name as filed: Foff Erin Pennock

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$3.4M
22 lines
Companies
1
with Form 4 filings
Latest transaction
Aug 17, 2026
transaction date

Roles and reported holdings

  • MPLTMapLight Therapeutics, Inc.
    Jan 27, 2026 – Aug 17, 2026

    Chief Medical Officer

    Held directly298,901 sh as of Jul 17, 2026 · Form 4

    24 months: $3.4M sold

Transaction history

All 27 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Aug 17, 2026MPLTChief Medical OfficerGrant or awardCode A · direct54,240—Form 4
Aug 17, 2026MPLTChief Medical OfficerGrant or awardCode A · direct13,360—Form 4
Jul 17, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct3,656$139K@ $37.90Form 4
Jul 16, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct19$721@ $37.96Form 4
Jul 16, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct5,865$219K@ $37.26Form 4
Jul 16, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct9,163$334K@ $36.46Form 4
Jul 15, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct18$676@ $37.54Form 4
Jul 15, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct8,972$332K@ $36.99Form 4
Jul 15, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct4,465$161K@ $36.00Form 4
Jul 15, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct7,845$291K@ $37.04Form 4
Jul 15, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct7,155$259K@ $36.16Form 4
May 7, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct117$3K@ $29.10Form 4
May 7, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct4,321$123K@ $28.52Form 4
May 6, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct15,900$463K@ $29.13Form 4
May 6, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct8,152$229K@ $28.04Form 4
May 5, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct931$27K@ $29.00Form 4
May 5, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct9,645$271K@ $28.12Form 4
May 4, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct700$21K@ $30.08Form 4
May 4, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct312$9K@ $29.56Form 4
May 4, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct5,460$155K@ $28.37Form 4
May 4, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct9,180$252K@ $27.50Form 4
Apr 16, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct881$24K@ $27.49Form 4
Apr 16, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct288$8K@ $27.01Form 4
Apr 15, 2026MPLTChief Medical OfficerOpen-market saleCode S · direct2,044$55K@ $26.84Form 4
Feb 5, 2026MPLTChief Medical OfficerGrant or awardCode A · direct54,240—Form 4
Feb 5, 2026MPLTChief Medical OfficerGrant or awardCode A · direct13,360—Form 4
Jan 27, 2026MPLTChief Medical OfficerShares withheld for tax or exercise priceCode F · direct44,616$802K@ $17.98Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.